ASM International NV (LON:0NX3)
534.80
-13.40 (-2.44%)
At close: Oct 17, 2025
ASM International NV Revenue
ASM International NV had revenue of 835.6 million EUR in the quarter ending June 30, 2025, with 18.34% growth. This brings the company's revenue in the last twelve months to 3.26 billion, up 25.47% year-over-year. In the year 2024, ASM International NV had annual revenue of 2.93 billion with 11.33% growth.
Revenue (ttm)
3.26B EUR
Revenue Growth
+25.47%
P/S Ratio
8.14
Revenue / Employee
715.76K EUR
Employees
4,558
Market Cap
22.77B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.93B | 298.39M | 11.33% |
Dec 31, 2023 | 2.63B | 223.40M | 9.27% |
Dec 31, 2022 | 2.41B | 681.02M | 39.37% |
Dec 31, 2021 | 1.73B | 401.79M | 30.25% |
Dec 31, 2020 | 1.33B | 44.26M | 3.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
British American Tobacco p.l.c. | 25.60B |